BAKER FELIX

USNatural personDirector

Transactions

1,433

Issuers

Buys / Sells

831/275

Last tx

02 Jan 2026

FrançaisSign in Try free 14d

Insider

BAKER FELIX

USNatural personDirector7 companies · 24mo

Transactions

1,433

Issuers

Buys / Sells

831/275

Last tx

02 Jan 2026

Behaviour

5 purchases reported after at least 12 months of silence — most recent on 30 Dec 2024.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
XOMA Royalty Corp	17,406,162	reported	09 Dec 2014	tx 17+120,300−392,353
BIOCRYST PHARMACEUTICALS INC	12,894,240	reported	05 Feb 2016	tx 1+45,000
BeOne Medicines Ltd.	10,699,954	reported	04 Jan 2021	tx 6−1,659,732
VIROPHARMA INC	9,840,469	reported	14 Dec 2011	tx 110+3,988,109−917,267
NEUROGEN CORP

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 100 buys in history.

1 month

+19.7%

Sample100

Win rate (≥5%)88%

Hit rate (>0)88%

3 months

+23.2%

Sample100

Win rate (≥5%)86%

Hit rate (>0)88%

6 months

+50.3%

Sample100

Win rate (≥5%)76%

Hit rate (>0)80%

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
02 Jan 2026	GRANT_AWARD	BICYCLE THERAPEUTICS PLC	19,000	0.00 USD
02 Jan 2026	GRANT_AWARD	BICYCLE THERAPEUTICS PLC	19,000	0.00 USD
02 Jan 2026	GRANT_AWARD	BICYCLE THERAPEUTICS PLC	38,000	0.00 USD	deriv
02 Jan 2026	GRANT_AWARD	BICYCLE THERAPEUTICS PLC	38,000	0.00 USD	deriv
31 Dec 2025	GRANT_AWARD	INCYTE CORP	328	0.00 USD
31 Dec 2025	GRANT_AWARD	INCYTE CORP	328	0.00 USD
11 Dec 2025	PURCHASE	Kymera Therapeutics, Inc.	167,192	86.00 USD
11 Dec 2025	PURCHASE	Kymera Therapeutics, Inc.	1,838,621	86.00 USD
20 Nov 2025	PURCHASE	Entrada Therapeutics, Inc.	13,082	9.07 USD
20 Nov 2025	PURCHASE	Entrada Therapeutics, Inc.	1,186	9.07 USD
20 Nov 2025	PURCHASE	Entrada Therapeutics, Inc.	13,386	9.07 USD
20 Nov 2025	PURCHASE	Entrada Therapeutics, Inc.	1,213	9.07 USD
30 Sept 2025	GRANT_AWARD	INCYTE CORP	388	0.00 USD
30 Sept 2025	GRANT_AWARD	INCYTE CORP	388	0.00 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	506	371.01 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	5,494	371.01 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	253	369.34 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	1,419	368.84 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	131	368.84 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	4,798	367.77 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	442	367.77 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	2,289	366.30 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	211	366.30 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	2,772	363.75 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	255	363.75 USD

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 100 buys in history.

1 month

+19.7%

Sample100

Win rate (≥5%)88%

Hit rate (>0)88%

3 months

+23.2%

Sample100

Win rate (≥5%)86%

Hit rate (>0)88%

6 months

+50.3%

Sample100

Win rate (≥5%)76%

Hit rate (>0)80%

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
XOMA Royalty Corp	17,406,162	reported	09 Dec 2014	tx 17+120,300−392,353
BIOCRYST PHARMACEUTICALS INC	12,894,240	reported	05 Feb 2016	tx 1+45,000
BeOne Medicines Ltd.	10,699,954	reported	04 Jan 2021	tx 6−1,659,732
VIROPHARMA INC	9,840,469	reported	14 Dec 2011	tx 110+3,988,109−917,267
NEUROGEN CORP

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
02 Jan 2026	GRANT_AWARD	BICYCLE THERAPEUTICS PLC	19,000	0.00 USD
02 Jan 2026	GRANT_AWARD	BICYCLE THERAPEUTICS PLC	19,000	0.00 USD
02 Jan 2026	GRANT_AWARD	BICYCLE THERAPEUTICS PLC	38,000	0.00 USD	deriv
02 Jan 2026	GRANT_AWARD	BICYCLE THERAPEUTICS PLC	38,000	0.00 USD	deriv
31 Dec 2025	GRANT_AWARD	INCYTE CORP	328	0.00 USD
31 Dec 2025	GRANT_AWARD	INCYTE CORP	328	0.00 USD
11 Dec 2025	PURCHASE	Kymera Therapeutics, Inc.	167,192	86.00 USD
11 Dec 2025	PURCHASE	Kymera Therapeutics, Inc.	1,838,621	86.00 USD
20 Nov 2025	PURCHASE	Entrada Therapeutics, Inc.	13,082	9.07 USD
20 Nov 2025	PURCHASE	Entrada Therapeutics, Inc.	1,186	9.07 USD
20 Nov 2025	PURCHASE	Entrada Therapeutics, Inc.	13,386	9.07 USD
20 Nov 2025	PURCHASE	Entrada Therapeutics, Inc.	1,213	9.07 USD
30 Sept 2025	GRANT_AWARD	INCYTE CORP	388	0.00 USD
30 Sept 2025	GRANT_AWARD	INCYTE CORP	388	0.00 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	506	371.01 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	5,494	371.01 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	253	369.34 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	1,419	368.84 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	131	368.84 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	4,798	367.77 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	442	367.77 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	2,289	366.30 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	211	366.30 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	2,772	363.75 USD
18 Aug 2025	PURCHASE	MADRIGAL PHARMACEUTICALS, INC.	255	363.75 USD